Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Previous Syphilis Alters the Course of Subsequent Episodes of Syphilis.

Marra CM, Maxwell CL, Sahi SK, Tantalo LC, Dunaway SB, Lukehart SA.

Clin Infect Dis. 2019 Sep 27. pii: ciz943. doi: 10.1093/cid/ciz943. [Epub ahead of print]

PMID:
31560366
2.

Neurosyphilis Treatment Outcomes After Intravenous Penicillin G versus Intramuscular Procaine Penicillin Plus Oral Probenecid.

Dunaway SB, Maxwell CL, Tantalo LC, Sahi SK, Marra CM.

Clin Infect Dis. 2019 Aug 23. pii: ciz795. doi: 10.1093/cid/ciz795. [Epub ahead of print]

PMID:
31504293
3.

Washington state satellite HIV clinic program: a model for delivering highly effective decentralized care in under-resourced communities.

Wood BR, Bell C, Carr J, Aleshire R, Behrens CB, Dunaway SB, Shah JA, Barnabas RV, Green ML, Ramers CB, Fina PL, Kim HN, Harrington RD.

AIDS Care. 2018 Sep;30(9):1120-1127. doi: 10.1080/09540121.2018.1481194. Epub 2018 May 31.

4.

Neurosyphilis Increases Human Immunodeficiency Virus (HIV)-associated Central Nervous System Inflammation but Does Not Explain Cognitive Impairment in HIV-infected Individuals With Syphilis.

Ho EL, Maxwell CL, Dunaway SB, Sahi SK, Tantalo LC, Lukehart SA, Marra CM.

Clin Infect Dis. 2017 Sep 15;65(6):943-948. doi: 10.1093/cid/cix473.

5.

Cerebrospinal Fluid Treponema pallidum Particle Agglutination Assay for Neurosyphilis Diagnosis.

Marra CM, Maxwell CL, Dunaway SB, Sahi SK, Tantalo LC.

J Clin Microbiol. 2017 Jun;55(6):1865-1870. doi: 10.1128/JCM.00310-17. Epub 2017 Apr 5.

6.

Reduced Treponema pallidum-Specific Opsonic Antibody Activity in HIV-Infected Patients With Syphilis.

Marra CM, Tantalo LC, Sahi SK, Dunaway SB, Lukehart SA.

J Infect Dis. 2016 Apr 15;213(8):1348-54. doi: 10.1093/infdis/jiv591. Epub 2015 Dec 9.

7.

Toll-like receptor polymorphisms are associated with increased neurosyphilis risk.

Marra CM, Sahi SK, Tantalo LC, Ho EL, Dunaway SB, Jones T, Hawn TR.

Sex Transm Dis. 2014 Jul;41(7):440-6. doi: 10.1097/OLQ.0000000000000149.

8.

Multiple-dose escalation study of the safety, pharmacokinetics, and biologic activity of oral AMD070, a selective CXCR4 receptor inhibitor, in human subjects.

Stone ND, Dunaway SB, Flexner C, Tierney C, Calandra GB, Becker S, Cao YJ, Wiggins IP, Conley J, MacFarland RT, Park JG, Lalama C, Snyder S, Kallungal B, Klingman KL, Hendrix CW.

Antimicrob Agents Chemother. 2007 Jul;51(7):2351-8. Epub 2007 Apr 23. Erratum in: Antimicrob Agents Chemother. 2007 Aug;51(8):3047.

Supplemental Content

Loading ...
Support Center